Literature DB >> 15922957

Genetic analysis of the antibody response to AAV2 and factor IX.

Huang-Ge Zhang1, Katherine A High, Qi Wu, PingAr Yang, Alex Schlachterman, Shaohua Yu, Nengjun Yi, Hui-Chen Hsu, John D Mountz.   

Abstract

We have analyzed the antibody response against either AAV2 or canine F.IX (cF.IX) in parental C57BL/6 (B6) and DBA/2 (D2) and 18 strains of B6 x D2 (BXD) recombinant inbred (RI) strains of mice after iv administration of AAV2-(ApoE)4/hAAT-cF.IX. There was a higher anti-AAV2 capsid response in B6 compared to D2 mice, with IgG2b being the major isotype separating the high and low responders in these two strains. In contrast, the antibody response to cF.IX was lower than the response to the AAV2 capsid and was limited to the IgG1 isotype in both strains. Genetic linkage analysis of the IgG2b anti-AAV2 antibody response in BXD RI strains revealed a significant locus at D4Mit164 (29 cM, LRS=15.3) and two suggestive loci at D6Mit16 (30.5 cM, LRS=11.2) and D17Mit187 (47.4 cM, LRS=13.1). Genetic linkage analysis of the IgG1 anti-cF.IX antibody response revealed a suggestive locus at D1Mit218 (67 cM, LRS=14.1). Significant epistatic interaction was found between two loci (D8Mit45 and D16Mit47; LOD=6.54) for anti-AAV2 and two other loci (D5Mit348 and D15Mit161; LOD=7.66) for anti-cF.IX. These results indicate that multiple genetic loci independently regulate the isotype-specific antibody response to the AAV2 capsid and the cF.IX transgene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922957     DOI: 10.1016/j.ymthe.2005.02.014

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  10 in total

1.  Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles.

Authors:  Chengwen Li; Nina Diprimio; Dawn E Bowles; Matthew L Hirsch; Paul E Monahan; Aravind Asokan; Joseph Rabinowitz; Mavis Agbandje-McKenna; R Jude Samulski
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B.

Authors:  Ou Cao; Brad E Hoffman; Babak Moghimi; Sushrusha Nayak; Mario Cooper; Shangzhen Zhou; Hildegund C J Ertl; Katherine A High; Roland W Herzog
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

Review 3.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 4.  Hepatic gene transfer as a means of tolerance induction to transgene products.

Authors:  Paul A LoDuca; Brad E Hoffman; Roland W Herzog
Journal:  Curr Gene Ther       Date:  2009-04       Impact factor: 4.391

5.  Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.

Authors:  Yu-Shan Tseng; Kim Van Vliet; Lavanya Rao; Robert McKenna; Barry J Byrne; Aravind Asokan; Mavis Agbandje-McKenna
Journal:  J Virol Methods       Date:  2016-07-14       Impact factor: 2.014

6.  Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction.

Authors:  Gabriella Cotugno; Patrizia Annunziata; Maria Vittoria Barone; Marianthi Karali; Sandro Banfi; Alberto Auricchio
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

7.  HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.

Authors:  Qiana L Matthews; Aiman Fatima; Yizhe Tang; Brian A Perry; Yuko Tsuruta; Svetlana Komarova; Laura Timares; Chunxia Zhao; Natalia Makarova; Anton V Borovjagin; Phoebe L Stewart; Hongju Wu; Jerry L Blackwell; David T Curiel
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

8.  Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy.

Authors:  Ana M Moreno; Nathan Palmer; Fernando Alemán; Genghao Chen; Andrew Pla; Ning Jiang; Wei Leong Chew; Mansun Law; Prashant Mali
Journal:  Nat Biomed Eng       Date:  2019-07-22       Impact factor: 25.671

9.  Diverse IgG subclass responses to adeno-associated virus infection and vector administration.

Authors:  Samuel L Murphy; Hojun Li; Federico Mingozzi; Denise E Sabatino; Daniel J Hui; Shyrie A Edmonson; Katherine A High
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

10.  Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.

Authors:  Qiana L Matthews; PingAr Yang; Qi Wu; Natalya Belousova; Angel A Rivera; Mariam A Stoff-Khalili; Reinhard Waehler; Hui-Chen Hsu; Zan Li; Jing Li; John D Mountz; Hongju Wu; David T Curiel
Journal:  Virol J       Date:  2008-08-21       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.